Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review. – PubMed – NCBI
https://www.ncbi.nlm.nih.gov/pubmed/29255847?dopt=Abstract
“CONCLUSION:
Evidence does not support use of the studied pharmacologic treatments for cognitive protection in persons with normal cognition or MCI.”—authors
Dr. Joris Wiggers 